Neuroprotective Effects of Melatonin during Demyelination and Remyelination Stages in a Mouse Model of Multiple Sclerosis. [electronic resource]
Producer: 20210208Description: 386-402 p. digitalISSN:- 1559-1166
- Animals
- Antioxidants -- therapeutic use
- Cuprizone -- toxicity
- Female
- Interleukin-1beta -- metabolism
- Locomotion
- Male
- Melatonin -- therapeutic use
- Mice
- Multiple Sclerosis -- drug therapy
- Myelin Sheath -- metabolism
- Neuroprotective Agents -- therapeutic use
- Oxidative Stress
- Sex Factors
- Tumor Necrosis Factor-alpha -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.